Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CardioComm Solutions Inc V.EKG

Alternate Symbol(s):  EKGGF

CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The Company is also engaged in manufacturing, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It has developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.


TSXV:EKG - Post by User

Bullboard Posts
Post by word99on Feb 13, 2019 8:46am
113 Views
Post# 29356993

NEWS OUT

NEWS OUTCardioComm Solutions Now Offers a Smartphone Connected FDA Cleared 12 Lead ECG Belt Under a New Co-Marketing Agreement The Novel 12 Lead ECG Belt will be Marketed into the US Hospital and Telemed Markets Toronto, Ontario--(Newsfile Corp. - February 13, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms it has entered into a device technology relationship for the co-marketing and US sales of a Smartphone connected 12 lead ECG wearable device. The announcement follows the successful integration and testing of the device with CardioComm's GlobalCardio ("GC") 12 FLEX remote ECG patient management platform and its hospital-based GEMS WIN software. Joint sales efforts will be launched during the 2019 Healthcare Information and Management Systems Society ("HIMSS") Global Conference & Exhibition in Orlando this week. HIMSS is expected to attract over 45,000 health information and technology professionals, clinicians, executives and market suppliers from around the world. The device is a simple to use, 12 lead ECG belt that is placed around the chest without the use of disposable supplies. The belt is intended for in-home use under a physician's prescription and can be placed properly without the need for any medical training. Once the belt is in place, ECGs are recorded and uploaded to a cloud service from where ECG files are pulled into CardioComm's software. GC12 FLEX and GEMS WIN provide an FDA cleared, back-office solution for centralized ECG data collection from remotely monitored patients. Physicians and/or ECG reading services can access their data securely for review and ECG reporting. GC12 FLEX also offers optional automated ECG interpretation to ease the ECG review process. GC12 and GEMS WIN are device agnostic solutions that offer healthcare professionals a simplified, "one-software-for-all-ECG-devices" single platform solution. CardioComm continues to seek out innovative hardware technologies that will provide reliable ECG monitoring of people outside of a hospital environments. The Company expects the 12 lead ECG belt will be of interest to its current hospital and physician group customer base, as well as to a growing number of remote and telemedicine patient management providers that are looking for ways to add ECG monitoring to their services. As part of the relationship the device manufacturer will promote the use of the CardioComm software to its growing client list looking to use 12 lead ECG monitoring within their operations. To learn more about CardioComm's products and for further updates regarding software releases and new device integrations, please visit the Company's websites at www.cardiocommsolutions.com and www.theheartcheck.com.
Bullboard Posts